Скачайте изображение (превью) выбрав качество

320x180 480x360 640x480 1280x720

We are joined onsite by Prof Carlo Pappone (IRCCS Policlinico San Donato, IT) who outlines the key findings of the BRUGADA Randomized trial.

In a randomized controlled trial, 150 patients with Brugada syndrome were enrolled in to develop an evidence-based treatment for the condition. Patients were randomized in a 2:1 fashion to receive either catheter ablation treatment with an ICD, or an ICD alone to evaluate the effectiveness of epicardial ablation in reducing rates of sudden cardiac death.

Questions:
1. What is the reasoning behind this study?
+ What are the unmet needs in the treatment of Brugada Syndrome?
2. What was the study design and patient population?
3. What are the key findings?
4. What could be the impact of these results on clinical practice?
5. What further research is needed?

Recorded at EHRA 2023, Barcelona.

Visit Radcliffe Cardiology:

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Like us on Facebook:
Follow us on Twitter:

Чтобы скачать видео "EHRA 23: BRUGADA Randomized: Epidcardial Ablation to Prevent Sudden Death" передвинте ползунок вправо